You are here: Industry Insights > recall

News List

Hikma Pharmaceuticals extends Ketorolac Tromethamine recall in US europeanpharmaceuticalreview
March 12, 2020
The FDA has announced that Hikma are now recalling certain lots of Ketorolac Tromethamine injections at the medical facility and retail levels.
MHRA announces two medicine recalls europeanpharmaceuticalreview
March 11, 2020
The Medicines and Healthcare products Regulatory Agency has issed two alerts for medicine recalls in the UK due to out of specification dissolution results and an error in decommissioning.
Two lots of Phenytoin Oral Suspension voluntarily recalled europeanpharmaceuticalreview
March 11, 2020
Taro Pharmaceuticals is recalling two lots of Phenytoin Oral Suspension USP due to concerns about failure to re-suspend resulting in under or overdosing.
Hikma Extends Recall of Ketorolac Tromethamine Injection americanpharmaceuticalreview
March 09, 2020
Hikma Pharmaceuticals announces its subsidiary Hikma Pharmaceuticals USA Inc. (formerly known as West-Ward Pharmaceuticals) is voluntarily extending its previously-announced recall of ...
FUSION IV Pharmaceuticals, AXIA Recalls All Sterile Drug Products americanpharmaceuticalreview
January 19, 2020
FUSION IV Pharmaceuticals dba AXIA Pharmaceutical is voluntarily recalling all unused sterile drug products within expiry, to the user level, due to a lack of assurance of sterility. The recalled sterile products have been found to be inconsistent with fe
Taro Issues Voluntary Nationwide Recall of Lamotrigine Tablets americanpharmaceuticalreview
January 16, 2020
Taro Pharmaceuticals is voluntarily recalling one (1) lot of Lamotrigine 100 mg Tablets, Lot # 331771 (expiration date June 2021) in 100 count bottles, NDC 51672-4131-1 to the consumer level.
Mylan Recalls Three Lots of Nizatidine Capsules americanpharmaceuticalreview
January 14, 2020
Mylan announced its U.S. based Mylan Pharmaceuticals business is conducting a voluntary nationwide recall, to the consumer level, of three lots of Nizatidine Capsules, USP (including the 150mg and 300mg strengths).
Taro Pharmaceuticals voluntarily recalls one lot of lamotrigine tablets europeanpharmaceuticalreview
January 14, 2020
Due to cross-contamination with enalapril maleate, Taro is voluntarily recalling one lot of its lamotrigine tablets at the consumer level.
FDA announces US recall of mirtazapine tablets due to mislabelled strength europeanpharmaceuticalreview
January 06, 2020
Aurobindo Pharma USA, Inc. has issued a voluntary nationwide recall of certain mirtazapine tablets as bottles labelled as 7.5mg may contain 15mg tablets.
Aurobindo Pharma Recalls Mirtazapine Tablets americanpharmaceuticalreview
January 03, 2020
Aurobindo Pharma USA is voluntarily recalling lot number 03119002A3 of Mirtazapine Tablets to the consumer level. The product is being recalled due to a label error on declared strength ...

Previous page 1 2 3 4 5 6 7 8 Next page